Dr. Gregg Semenza

Professor of Genetic Medicine and founding Director of the Vascular Program in the Institute for Cell Engineering at the Johns Hopkins University School of Medicine, he is also an elected member of Nacional Academies of Medicine and Science.

Dr Semenza has been awarded multiple important scientific prizes for his remarkable work, such as the Albert Lasker Basic Medical Research Award, and the 2019 Nobel Prize in Physiology or Medicine, for his groundbreaking discoveries on hypoxia-inducible factors which direct transcriptional responses to decreased O2 availability and play roles in the pathophysiology of cardiovascular disorders, cancer, and many other diseases.